OCUSERT PILO-20 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ocusert Pilo-20, and when can generic versions of Ocusert Pilo-20 launch?
Ocusert Pilo-20 is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in OCUSERT PILO-20 is pilocarpine. There are twelve drug master file entries for this compound. Additional details are available on the pilocarpine profile page.
US Patents and Regulatory Information for OCUSERT PILO-20
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | OCUSERT PILO-20 | pilocarpine | INSERT, EXTENDED RELEASE;OPHTHALMIC | 017431-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
